Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
about
Looking for sputum biomarkers in lung cancer secondary prevention: where are we now?Sputum-based DNA methylation biomarkers to guide lung cancer screening decisions.Gene Promoter Hypermethylation Detected in Sputum Predicts FEV1 Decline and All-cause Mortality in Smokers.An epigenetic classifier for early stage lung cancer.
P2860
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@en
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@nl
type
label
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@en
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@nl
prefLabel
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@en
Gene methylation biomarkers in sputum as a classifier for lung cancer risk.
@nl
P2093
P2860
P356
P1433
P1476
Gene methylation biomarkers in sputum as a classifier for lung cancer risk
@en
P2093
Christine A Stidley
Cynthia L Thomas
Daniel D Karp
Donna M Klinge
Elia Casas
Fadlo R Khuri
Jill M Siegfried
Maria A Picchi
Sandra J Lee
Seena Aisner
P2860
P304
63978-63985
P356
10.18632/ONCOTARGET.19255
P407
P50
P577
2017-07-15T00:00:00Z